Literature DB >> 22249253

A role for Mediator complex subunit MED13L in Rb/E2F-induced growth arrest.

S P Angus1, J R Nevins.   

Abstract

The Rb/E2F pathway is deregulated in virtually all human tumors. It is clear that, in addition to Rb itself, essential cofactors required for transcriptional repression and silencing of E2F target genes are mutated or lost in cancer. To identify novel cofactors required for Rb/E2F-mediated inhibition of cell proliferation, we performed a genome-wide short hairpin RNA screen. In addition to several known Rb cofactors, the screen identified components of the Mediator complex, a large multiprotein coactivator required for RNA polymerase II transcription. We show that the Mediator complex subunit MED13L is required for Rb/E2F control of cell growth, the complete repression of cell cycle target genes, and cell cycle inhibition.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22249253      PMCID: PMC3707121          DOI: 10.1038/onc.2011.622

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  65 in total

1.  The human CDK8 subcomplex is a molecular switch that controls Mediator coactivator function.

Authors:  Matthew T Knuesel; Krista D Meyer; Carrie Bernecky; Dylan J Taatjes
Journal:  Genes Dev       Date:  2009-02-15       Impact factor: 11.361

2.  E2F1 represses beta-catenin transcription and is antagonized by both pRB and CDK8.

Authors:  Erick J Morris; Jun-Yuan Ji; Fajun Yang; Luisa Di Stefano; Anabel Herr; Nam-Sung Moon; Eun-Jeong Kwon; Kevin M Haigis; Anders M Näär; Nicholas J Dyson
Journal:  Nature       Date:  2008-09-14       Impact factor: 49.962

Review 3.  Hijacking the chromatin remodeling machinery: impact of SWI/SNF perturbations in cancer.

Authors:  Bernard Weissman; Karen E Knudsen
Journal:  Cancer Res       Date:  2009-10-20       Impact factor: 12.701

4.  Dissecting the unique role of the retinoblastoma tumor suppressor during cellular senescence.

Authors:  Agustin Chicas; Xiaowo Wang; Chaolin Zhang; Mila McCurrach; Zhen Zhao; Ozlem Mert; Ross A Dickins; Masashi Narita; Michael Zhang; Scott W Lowe
Journal:  Cancer Cell       Date:  2010-04-13       Impact factor: 31.743

Review 5.  Senescence in tumours: evidence from mice and humans.

Authors:  Manuel Collado; Manuel Serrano
Journal:  Nat Rev Cancer       Date:  2010-01       Impact factor: 60.716

Review 6.  The metazoan Mediator co-activator complex as an integrative hub for transcriptional regulation.

Authors:  Sohail Malik; Robert G Roeder
Journal:  Nat Rev Genet       Date:  2010-10-13       Impact factor: 53.242

7.  CDK8 is a colorectal cancer oncogene that regulates beta-catenin activity.

Authors:  Ron Firestein; Adam J Bass; So Young Kim; Ian F Dunn; Serena J Silver; Isil Guney; Ellen Freed; Azra H Ligon; Natalie Vena; Shuji Ogino; Milan G Chheda; Pablo Tamayo; Stephen Finn; Yashaswi Shrestha; Jesse S Boehm; Supriya Jain; Emeric Bojarski; Craig Mermel; Jordi Barretina; Jennifer A Chan; Jose Baselga; Josep Tabernero; David E Root; Charles S Fuchs; Massimo Loda; Ramesh A Shivdasani; Matthew Meyerson; William C Hahn
Journal:  Nature       Date:  2008-09-14       Impact factor: 49.962

Review 8.  Cellular mechanisms of tumour suppression by the retinoblastoma gene.

Authors:  Deborah L Burkhart; Julien Sage
Journal:  Nat Rev Cancer       Date:  2008-09       Impact factor: 60.716

9.  The ZNF217 oncogene is a candidate organizer of repressive histone modifiers.

Authors:  Michaela S Banck; Side Li; Hitomi Nishio; Cheng Wang; Andreas S Beutler; Martin J Walsh
Journal:  Epigenetics       Date:  2009-02-23       Impact factor: 4.528

10.  RUNX1 and its fusion oncoprotein derivative, RUNX1-ETO, induce senescence-like growth arrest independently of replicative stress.

Authors:  K Wolyniec; S Wotton; A Kilbey; A Jenkins; A Terry; G Peters; C Stocking; E Cameron; J C Neil
Journal:  Oncogene       Date:  2009-05-18       Impact factor: 9.867

View more
  15 in total

1.  Mediator complex component MED13 regulates zygotic genome activation and is required for postimplantation development in the mouse.

Authors:  Yi-Liang Miao; Andrés Gambini; Yingpei Zhang; Elizabeth Padilla-Banks; Wendy N Jefferson; Miranda L Bernhardt; Weichun Huang; Leping Li; Carmen J Williams
Journal:  Biol Reprod       Date:  2018-04-01       Impact factor: 4.285

2.  Molecular impact of selective NFKB1 and NFKB2 signaling on DLBCL phenotype.

Authors:  X Guo; J L Koff; A B Moffitt; M Cinar; S Ramachandiran; Z Chen; J M Switchenko; M Mosunjac; S G Neill; K P Mann; M Bagirov; Y Du; Y Natkunam; H J Khoury; M R Rossi; W Harris; C R Flowers; I S Lossos; L H Boise; S S Dave; J Kowalski; L Bernal-Mizrachi
Journal:  Oncogene       Date:  2017-04-03       Impact factor: 9.867

3.  Novel de novo heterozygous loss-of-function variants in MED13L and further delineation of the MED13L haploinsufficiency syndrome.

Authors:  Concetta Cafiero; Giuseppe Marangi; Daniela Orteschi; Marwan Ali; Alessia Asaro; Emanuela Ponzi; Alice Moncada; Stefania Ricciardi; Marina Murdolo; Giorgia Mancano; Ilaria Contaldo; Vincenzo Leuzzi; Domenica Battaglia; Eugenio Mercuri; Anne M Slavotinek; Marcella Zollino
Journal:  Eur J Hum Genet       Date:  2015-02-25       Impact factor: 4.246

4.  Dosage changes of MED13L further delineate its role in congenital heart defects and intellectual disability.

Authors:  Reza Asadollahi; Beatrice Oneda; Frenny Sheth; Silvia Azzarello-Burri; Rosa Baldinger; Pascal Joset; Beatrice Latal; Walter Knirsch; Soaham Desai; Alessandra Baumer; Gunnar Houge; Joris Andrieux; Anita Rauch
Journal:  Eur J Hum Genet       Date:  2013-02-13       Impact factor: 4.246

5.  Genome-wide association study in Chinese identifies novel loci for blood pressure and hypertension.

Authors:  Xiangfeng Lu; Laiyuan Wang; Xu Lin; Jianfeng Huang; C Charles Gu; Meian He; Hongbing Shen; Jiang He; Jingwen Zhu; Huaixing Li; James E Hixson; Tangchun Wu; Juncheng Dai; Ling Lu; Chong Shen; Shufeng Chen; Lin He; Zengnan Mo; Yongchen Hao; Xingbo Mo; Xueli Yang; Jianxin Li; Jie Cao; Jichun Chen; Zhongjie Fan; Ying Li; Liancheng Zhao; Hongfan Li; Fanghong Lu; Cailiang Yao; Lin Yu; Lihua Xu; Jianjun Mu; Xianping Wu; Ying Deng; Dongsheng Hu; Weidong Zhang; Xu Ji; Dongshuang Guo; Zhirong Guo; Zhengyuan Zhou; Zili Yang; Renping Wang; Jun Yang; Xiaoyang Zhou; Weili Yan; Ningling Sun; Pingjin Gao; Dongfeng Gu
Journal:  Hum Mol Genet       Date:  2014-09-23       Impact factor: 6.150

Review 6.  The Mediator complex of Caenorhabditis elegans: insights into the developmental and physiological roles of a conserved transcriptional coregulator.

Authors:  Jennifer M Grants; Grace Y S Goh; Stefan Taubert
Journal:  Nucleic Acids Res       Date:  2015-01-29       Impact factor: 16.971

7.  Expression of the lncRNA Maternally Expressed Gene 3 (MEG3) Contributes to the Control of Lung Cancer Cell Proliferation by the Rb Pathway.

Authors:  Traci L Kruer; Susan M Dougherty; Lindsey Reynolds; Elizabeth Long; Tanya de Silva; William W Lockwood; Brian F Clem
Journal:  PLoS One       Date:  2016-11-10       Impact factor: 3.240

8.  Integrated model of de novo and inherited genetic variants yields greater power to identify risk genes.

Authors:  Xin He; Stephan J Sanders; Li Liu; Silvia De Rubeis; Elaine T Lim; James S Sutcliffe; Gerard D Schellenberg; Richard A Gibbs; Mark J Daly; Joseph D Buxbaum; Matthew W State; Bernie Devlin; Kathryn Roeder
Journal:  PLoS Genet       Date:  2013-08-15       Impact factor: 5.917

9.  Single-cell RNA sequencing reveals T helper cells synthesizing steroids de novo to contribute to immune homeostasis.

Authors:  Bidesh Mahata; Xiuwei Zhang; Aleksandra A Kolodziejczyk; Valentina Proserpio; Liora Haim-Vilmovsky; Angela E Taylor; Daniel Hebenstreit; Felix A Dingler; Victoria Moignard; Berthold Göttgens; Wiebke Arlt; Andrew N J McKenzie; Sarah A Teichmann
Journal:  Cell Rep       Date:  2014-05-10       Impact factor: 9.423

10.  Genomic alterations of ground-glass nodular lung adenocarcinoma.

Authors:  Hyun Lee; Je-Gun Joung; Hyun-Tae Shin; Duk-Hwan Kim; Yujin Kim; Hojoong Kim; O Jung Kwon; Young Mog Shim; Ho Yun Lee; Kyung Soo Lee; Yoon-La Choi; Woong-Yang Park; D Neil Hayes; Sang-Won Um
Journal:  Sci Rep       Date:  2018-05-16       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.